Vitale, Alessandra
Strisciuglio, Caterina
Vitale, Serena
Santopaolo, Marianna
Bruzzese, Dario
Micillo, Teresa
Scarpato, Elena
Miele, Erasmo
Staiano, Annamaria
Troncone, Riccardo
Matarese, Giuseppe
Gianfrani, Carmen
Article History
Received: 16 January 2019
Revised: 26 July 2019
Accepted: 9 September 2019
First Online: 12 November 2019
Competing interests
: The authors declare no competing interests and no funding to disclose with regard to this paper; A.S. served as investigator and member of advisory board for the following companies: D.M.G, Valeas, Angelini, Miltè, Danone, Nestlé, Sucampo, Menarini. E.M. served as investigator and member of advisory board for the following companies: Abbvie, Angelini, Bioprojet, Ferring, Menarini, Milte, Valeas; G.M. served as investigator and member of advisory board for the following companies: Merck, Biogen, Novartis, Aegerion. C.G. served as investigator and member of advisory board for Nemysis.